You are using an outdated browser. Please upgrade your browser to improve your experience.

CAPABILITIES

Global equities

Beyond market cycles. Beyond the expected.

OVERVIEW

Global equity investing at Royal London Asset Management

We believe that equities represent an opportunity for you to participate in the significant long-term wealth created by companies across the world.

In a crowded marketplace, our global equity team delivers a differentiated, proven and repeatable long-term approach – designed to perform in all market conditions.

Why Royal London Asset Management for global equity?

Bio Image
Wealth creation

Our process is designed to identify stocks that we believe have superior shareholder wealth creation potential, at attractive prices

Bio Image
Differentiated returns

The Corporate Life Cycle sits at the heart of an innovative process, designed to generate returns across market conditions

Bio Image
Robust process

We use a blend of qualitative and quantitative tools to skew outcomes in our favour

Our approach

We believe that business fundamentals are the long-term drivers of stock prices. However, we recognise that different fundamentals matter at different points of a company’s life, and that these are often unappreciated or misunderstood by the market.

Our approach therefore aims to identify and exploit these inefficiencies, identifying stocks that we believe have superior shareholder wealth creation potential, at attractive prices.

We use custom tools, technology and data to identify neglected opportunities and manage the complexity of global equity markets. We use this data within a proprietary framework to help drive our analysis, with our Corporate Life Cycle concept sitting at the heart of this.

Global equities - Corporate Life Cycle.png

We consider that corporate returns on productive capital and growth tend to progress along a Life Cycle and every company can be located economically in one of five Life Cycle categories, from early stage accelerators and growth compounders to more mature returners and turnarounds.

The five categories of the Life Cycle are illustrated above, with each one dictating the path of analysis in our investment process.

Importantly, while wealth creation can occur across the entire Corporate Life Cycle, the drivers of success are very different depending on what stage of the Life Cycle the company is in.

Process

The investment process that underpins all our global equity strategies has been built around three key
stages, each of which we believe has proven advantages and efficacy.

Bio Image
Idea generation

This involves the measurement and classification of our universe of stocks which comprises over 5,000 companies. We use our Economic Return Framework to measure all companies in our universe. 

Bio Image
Portfolio construction

Our implementation seeks to maximise our information ratios around various client guidelines both in terms of risk/return budgets and more tailored outcome considerations such as income requirements and climate mitigation levels.

Bio Image
Research and stock selection

This begins with an identification of the 600 or so most promising investment opportunities which we put through and our qualitative Shareholder Wealth Creation Test.

Our funds

Bio Image
RL Global Equity Diversified Fund

Region: Global
Fund launch: 2 December 2025
Benchmark: MSCI All Countries World Net Total Return Index AUD

Bio Image
RL Global Equity Enhanced Fund

Region: Global
Fund launch: 2 December 2025
Benchmark: MSCI World Index AUD

Bio Image
RL Global Equity Select Fund

Region: Global
Fund launch: 2 December 2025
Benchmark: MSCI World Net Total Return Index AUD

For further information on these funds, including pricing, please visit the EQT website

Go to EQT website

Literature

 

Past performance is not a guide to future performance. The value of investments and any income from them may go down as well as up and is not guaranteed. Investors may not get back the amount invested.

The reports that included the ratings were published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec) for ETL1443AU, ETL2299AU and ETL1397AU on 19/08/2026. Lonsec receives a fee from fund managers for the preparation of reports. The report / rating is general advice only. An investor should be aware that: a) the advice has been prepared without taking into account an investors’ objectives, financial situation or needs; b) an investor should consider the appropriateness of the advice having regard to their own objectives, financial situation or needs before acting on the advice; and c) an investor should obtain a PDS relating to the product, consider the PDS and seek independent financial advice before making any decision about whether to acquire the product. The rating is not a recommendation to purchase, sell or hold any product. Ratings are prepared based on information available at the time of preparation and may be subject to change by Lonsec without notice. Visit lonsec.com.au for important documents (FSG, Conflicts Statement). © 2026 Lonsec. All rights reserved.

Equity Trustees Limited (“Equity Trustees”) (ABN 46 004 031 298), AFSL 240975, is the Responsible Entity for the Royal London Global Equity Diversified Fund, Royal London Global Equity Enhanced Fund, and Royal London Global Equity  Select (“the Funds”). Equity Trustees is a subsidiary of EQT Holdings Limited (ABN 22 607 797 615), a publicly listed company on the Australian Securities Exchange (ASX: EQT).

This website has been prepared by Royal London Asset Management to provide you with general information only. In preparing this website, we did not take into account the investment objectives, financial situation or particular needs of any particular person. It is not intended to take the place of professional advice and you should not take action on specific issues in reliance on this information. Neither Royal London Asset Management, Equity Trustees nor any of its related parties, their employees or directors, provide any warranty of accuracy or reliability in relation to such information or accepts any liability to any person who relies on it. You should obtain a copy of the Product Disclosure Statement and the Funds’ Target Market Determination (available at www.eqt.com.au/insto) before making a decision about whether to invest in this product.

Contact us